HarborSite
harborsite.com
Actively hiring
Cell & Gene Therapy
Biotechnology
Synthetic Biology
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Backers
1
SmartGateVC
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
SmartGateVC Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.
EditCo provides CRISPR gene editing services, CRISPR products & genome engineering solutions for disease models, drug discovery and cell…
Cell and Gene Therapy. Cure Genetics Committed to the development of gene and cell therapy for oncology and genetic diseases Cure Genetics…
Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies…
Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Skyline Therapeutics is a fully integrated gene therapy company dedicated to the discovery, development and delivery of innovative…
News
Kicking Off the Second Cohort of the AI BioHub Accelerator Program -…
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. Learn more!
Read more
Report
HarborSite: Precise and Efficient Gene Editing for Next-Generation Gene Therapies
Integration of therapeutic genes into genomic safe harbors using highly specific and efficient recombinases could enable more predictable, safe and durable gene therapies
Read more
Report
Human Genomic Safe Harbors Identified for Gene and Cell Therapy
Researchers validate genomic safe harbors for therapeutic genes, enabling safer, more efficient, and predictable gene and cell therapies.
Read more
Report